after a successful cyst fenestration; 9, 11, 12, 15 however, there is no clear explanation for the pathogenesis of subsequent intracranial hypertension and the risk factors for shunt placement after fenestration. The middle cranial fossa is the most common location for intracranial arachnoid cysts, and obstructive hydrocephalus is uncommon. Thus, it is speculated that a latent derangement of CSF circulation becomes clinically evident following cyst fenestration.
In our study, we retrospectively reviewed a single-institution experience with 26 pediatric patients (21 symptomatic, 5 asymptomatic with large cysts) who underwent surgical treatment of middle cranial fossa arachnoid cysts during a 9-year period and evaluated the risk factors for shunt placement following a successful cyst fenestration. In addition, we discussed the optimal surgical indications for the treatment of middle cranial fossa arachnoid cysts in children.
methods

Patient Population
From the retrospective analysis of 35 endoscopic or microsurgical cyst fenestrations performed for various intracranial arachnoid cysts between April 2004 and March 2013 in the Department of Neurosurgery, Miyagi Children's Hospital, 26 pediatric patients (defined as age < 18 years) with middle cranial fossa arachnoid cysts were studied in this report. Patients with a follow-up period of less than 1 year were excluded. Our surgical indications for middle cranial fossa arachnoid cysts were as follows: 1) arachnoid cysts associated with symptoms such as headache and abnormally enlarging head circumference; 2) progressively expanding arachnoid cysts; and 3) large arachnoid cysts such as Galassi Type III.
data collection
Preoperatively, we recorded age, sex, presenting symptoms, and the presence of increased head circumference, progressive cyst expansion, and subdural hematoma/hygroma for each patient. Abnormal head enlargement was defined as a head circumference greater than 2 standard deviations above the mean or greater than the 98th percentile. The radiological studies, including CT and MRI, were evaluated for any changes in cyst size, usually in the axial plane; cyst enlargement was determined by a consistent numerical increase in size in at least 2 consecutive measurements. Statistical analysis was performed using JMP software (version 11, SAS Institute Inc.).
surgical treatment
All patients were operated on as a primary surgery without any history of microsurgical and/or endoscopic treatment, or any shunt placement. First, we performed cyst fenestration to avoid shunt-related complications such as shunt malfunction, infection, over-shunting, and shunt dependency. 13 A drain catheter was inserted in only 1 patient (Case 25). Medical treatments including steroid and/ or glycerol administration were not performed preoperatively in all of the patients. The patients were clinically assessed postoperatively regarding any improvement or worsening of preoperative symptoms, the occurrence of intracranial hypertension requiring subsequent shunt placement, and changes in cyst volume. All patients were evaluated via CT and/or MRI studies pre-and postoperatively.
results
Patient characteristics
There were 26 patients with middle cranial fossa arachnoid cysts at the time of fenestration (Table 1) . This patient population included 17 males and 9 females, with an age range from 9 months to 15 years (median 7.8 years). Clinical manifestations on diagnosis included intermittent vomiting and/or headache in 15 patients, large asymptomatic arachnoid cysts in 7 patients, head enlargement in 2 patients, and developmental delays in 2 patients. In a detailed analysis of head circumference growth curves, 8 patients (including 2 asymptomatic patients [Cases 15 and 24]) displayed abnormally enlarging head circumference greater than 2 standard deviations above the mean or greater than the 98th percentile, meaning that this study actually included 5 asymptomatic patients. Preoperative cyst expansion was found in 4 patients (age range 11 months to 2 years). Younger age was significantly correlated with progressive cyst expansion in patients with untreated middle cranial fossa arachnoid cysts (mean age 1.6 vs 9.0 years, respectively; p < 0.01, Wilcoxon signedrank test), whereas no patients older than 3 years exhibited cyst expansion during follow-up. Subdural hematoma/hygroma was recognized in 4 patients at the time of initial diagnosis (age range 3-5 years). These clinical characteristics are shown in Table 1 .
surgical treatment
Microsurgical cyst fenestration was performed in 25 patients with middle cranial fossa arachnoid cysts. An external subdural drain catheter was inserted in 1 patient (Case 25) simultaneously with fenestration because this patient exhibited subdural hygroma and severe papilledema before fenestration. In brief, under general anesthesia, a 5-cm-long linear skin incision was made behind the hairline, and a 3-cm cranial flap was removed. At this stage, the microscope was brought into the surgical field, and the dura mater was opened and sutured with the outer arachnoid membranes to prevent postoperative hygroma. Sharp dissection of the deep inner arachnoid membranes and the membrane of Liliequist was performed using microscissors to communicate with the deep basal cisterns. Endoscopic fenestration was performed in 1 patient (Case 22). Four patients (Cases 5, 7, 13, and 25) continued to exhibit and/or developed signs of raised ICP. Three patients (Cases 5, 7, and 13) exhibited markedly increased subcutaneous CSF effusion, and the other patient (Case 25) displayed CSF drainage exceeding 300 ml/day after microsurgical fenestration. These 4 patients required subsequent cystoperitoneal shunting (age range 11 months to 4 years) irrespective of fenestration. Shunt placement was performed within 1 month after fenestration (range 6 days to 1 month) with Medtronic Strata programmable valves for 3 patients (Cases 5, 7, and 25) and a Medtronic medi-um-pressure nonprogrammable valve for 1 patient (Case 13). No asymptomatic patients underwent shunt placement. Statistical analysis identified younger age (mean 2.1 vs 8.9 years old, respectively; p < 0.01, Wilcoxon signedrank test; Fig. 1 ), abnormal head enlargement (37.5% vs 5.6%, respectively; p < 0.05, chi-square test; Fig. 2 ), and progressive cyst expansion (75.0% vs 4.6%, respectively; p < 0.001, chi-square test; Fig. 3 ) before fenestration as significantly correlated with the need for shunt placement in pediatric patients with middle cranial fossa arachnoid cysts.
Postoperative complications and outcome
There were no perioperative deaths or permanent neurological defects. Two patients (Cases 5 and 19) developed ipsilateral subdural hygroma after microsurgical fenestration, which gradually diminished. There was 1 case of shunt infection during the follow-up period.
The mean follow-up period was 37.3 months. There were no excluded patients for the assessment of the shunt placement. Intermittent vomiting, headache, and head enlargement because of increased ICP were resolved or improved in all patients. Two patients who had developmental delays did not display any improvement (Cases 10 and 13).
Radiologically, arachnoid cysts were reduced in size (< 50%) or nearly resolved (< 90%) in 22 patients (84.6%) after fenestration and/or shunt placement, whereas in the remaining 2 patients (Cases 2 and 22, 7.7%), there was no postoperative change in cyst size. Because of the subdural hygroma, radiological evaluation could not be performed in 2 patients (Cases 5 and 19). Regarding the 5 asymptomatic patients (Cases 3, 6, 12, 18, and 26), the arachnoid cysts had almost disappeared in 3 patients and had decreased in size in 2 patients. The presence of symptoms was not statistically associated with cyst size after fenestration in pediatric patients with middle cranial fossa arachnoid cysts. In addition, of the 4 patients who required shunt placement, 2 (Cases 7 and 25) showed enlargement of the ventricle size after cyst fenestration because mass effects on adjacent brain parenchyma by arachnoid cysts were reduced, but their enlarged ventricles did not decrease in size after shunt placement (Fig. 4) . The other 2 patients (Cases 5 and 13) did not show any changes in ventricle size after fenestration and shunting. Only 1 patient (Case 25) suffered from vomiting 1 year after shunt placement, and we assessed her shunt patency with a shunt contrast study. Her shunt catheter was patent over the entire length of the shunt.
illustrative cases case 7 A 1-year-old boy was presented to our clinic with a history of progressive head enlargement (from 45.4 cm at 4 months to 51.2 cm at 9 months; Fig. 4A) . A head CT scan uncovered a large left middle cranial fossa arachnoid cyst (Fig. 4B) . He underwent microsurgical cyst fenestration because he was symptomatic. After surgery, he was fretful and irritable, and a markedly increasing subcutaneous CSF effusion at the incision site developed in a pseudomeningocele-like manner. Because his clinical characteristics were consistent with elevated ICP, cystoperitoneal shunt placement was performed 1 week after fenestration. The symptoms associated with increased ICP and the preexisting arachnoid cyst resolved after shunt placement (Fig. 4C) .
case 18
An 8-year-old boy was presented to our clinic after hitting his head in a car accident. Clinically, he was normal and underwent a CT examination, which disclosed a huge left middle cranial fossa arachnoid cyst classified as Galassi Type III (Fig. 5B) . Because of the large cyst size, microsurgical fenestration was performed without complications (Fig. 5A) . The arachnoid cyst decreased in size dramatically after the fenestration (Fig. 5C ).
discussion shunt Placement after cyst Fenestration
In this study we found that younger age, head enlargement, and cyst expansion were risk factors for shunt placement following cyst fenestration in patients with middle cranial fossa arachnoid cysts. The pathogenesis explaining why a latent derangement of CSF circulation becomes clinically evident after fenestration has not been clearly elucidated. However, some patients with middle cranial fossa arachnoid cysts experience an accumulation of CSF and increased ICP after cyst fenestration. It has been reported that the subsequent shunt placements after fenestration were required in 4.0%-24.1% of the patients with middle cranial fossa arachnoid cysts. 12, 15 In our study, 4 pediatric patients (15.4%) required CSF conversion with shunt placement after cyst fenestration. Among these patients, 3 displayed increasing subcutaneous CSF effusion in a pseudomeningocele-like manner at the incision site, suggesting elevated ICP. For the remaining patient, a CSF drain catheter was placed at the same time as fenestration because of severe preoperative papilledema. Because more than 300 ml of CSF was drained from the drain catheter each day, cystoperitoneal shunting was performed following fenestration in this patient. The indication of the subsequent shunt placement after fenestration is important but still controversial. We should always consider that it might be a transient overproduction of the CSF due Fig. 2 . Bar graph illustrating the number of pediatric patients with middle cranial fossa arachnoid cysts with (+) or without (-) macrocephaly, and with (+) or without (-) shunt placement. Macrocephaly was a significant risk factor for shunt placement after cyst fenestration (37.5% vs 5.6%, respectively). **p < 0.05, chi-square test. Fig. 3 . Bar graph illustrating the number of pediatric patients with middle cranial fossa arachnoid cysts with (+) or without (-) progressive cyst expansion and with (+) or without (-) shunt placement. Progressive cyst expansion was a significant risk factor for shunt placement after cyst fenestration (75.0% vs 4.6%, respectively). **p < 0.001, chi-square test. Fig. 1 . Scatterplot illustrating the prevalence of pediatric patients with middle cranial fossa arachnoid cysts (by age in years) who did or did not require shunt placement after cyst fenestration. Younger age was a statistically significant risk factor for shunt placement after fenestration (mean age 2.1 vs 8.9 years, respectively; p < 0.01, Wilcoxon signed-rank test). Mean represented by the middle horizontal line in each category.
to some factors such as operative stress or aseptic and/or chemical meningitis.
There are few reports regarding risk factors for shunt placement following cyst fenestration in pediatric patients with middle cranial fossa arachnoid cysts. Levy et al. reported 40 children with middle cranial fossa arachnoid cysts treated in their hospital, including 6 patients with ventriculomegaly, 9 patients with macrocephaly but without ventriculomegaly, and 25 patients with normocephaly. All 6 patients with ventriculomegaly required both fenestration and shunt placement. In total, 5 of 9 patients with macrocephaly but without ventriculomegaly, and only 1 patient with normocephaly, underwent initial cyst fenestration and subsequent shunt placement. 11 Our findings concur with theirs, and these results suggest that patients with middle cranial fossa arachnoid cysts with abnormally enlarging head circumference harbor a latent aberration of CSF circulation and require shunt placement. Younger age and cyst enlargement before fenestration were also risk factors for shunt placement after fenestration in pediatric patients with middle cranial fossa arachnoid cysts. In our study, all patients with cyst expansion before surgery were less than 2 years old, and a younger age itself was significantly correlated with cyst expansion. Al-Holou et al. performed a survey of the natural history of 111 arachnoid cysts in pediatric patients, of which 11 increased in size. 2 This survey attested that a younger age (< 4 years old) at initial presentation was significantly as- sociated with cyst enlargement, and a larger initial cyst size was related to the presence or development of symptoms and the need for surgery. In contrast, Lee et al. also identified a younger age at diagnosis to be the only significant factor affecting cyst enlargement, but their findings indicated that children with asymptomatic enlargement of arachnoid cysts should not undergo surgery because the risks and complications of surgery were not negligible, adding that close follow-up was an option for such children.
3,10 Because progressive cyst enlargement and abnormal head enlargement are more likely to occur in younger children, it is possible that this age group can be the only determining factor and at higher risk for shunt placement after fenestration. Because of the small sample size, multivariate analysis could not be performed in this study.
cyst reduction after treatment and surgical indication
The initial treatment in our study was successful, as the middle cranial fossa arachnoid cysts decreased in size or almost disappeared in 22 patients (84.6%) after fenestration and/or shunt placement. There were no significant differences in cyst reduction between symptomatic and asymptomatic patients. Regarding the 5 asymptomatic patients with large cysts, the arachnoid cysts had almost disappeared in 3 patients after the fenestration, whereas they had decreased in size in the remaining patients, suggesting that the arachnoid cysts compressed adjacent neural structures even if they appeared to be asymptomatic. Di Rocco et al. implanted ICP sensors in the brain parenchyma adjacent to the cysts in patients and recorded preoperative ICP for 48 hours. They reported that ICP is almost constantly elevated in children with Galassi Type III cysts. 5 Their results indicate that the adjacent brain parenchyma is locally compressed by arachnoid cysts.
There are no guidelines for the treatment of arachnoid cysts, and most authors agree with treating symptomatic patients with hydrocephalus, elevated ICP, and obvious focalizing symptoms. However, clinical judgment can be difficult when nonspecific symptoms such as headaches, psychosis, or seizures are present. In some cases, the clinician may suspect that the cyst is causing nonspecific difficulties such as developmental delay or other cognitive problems. Wester et al. proposed the possibility that the impairment of higher cognitive functions is reversible after surgical cyst decompression. 8, 17 As described previously, it is unclear whether local compression of the underlying cerebral parenchyma by arachnoid cysts can have adverse effects on brain functions and development. Certainly, it is difficult to investigate the functional and developmental impairments caused by chronic local brain compression due to arachnoid cysts, but we can consider the potential of prophylactic treatment for large asymptomatic arachnoid cysts such as Galassi Type III lesions to protect the developing brain in pediatric patients. In addition to the consensus that symptomatic arachnoid cysts should be treated, we believe that, in children, arachnoid cysts documented as causing significant displacement of normal brain structures warrant surgical treatment to protect brain development.
Children with arachnoid cysts are also at risk for intracystic or subdural hemorrhage occurring spontaneously or after a minor head injury.
1,14 A more recent publication by Cress et al. involved a case-control study to determine whether an association exists among the rupture of arachnoid cysts, cyst size, and recent head injury. These authors found that 6% of arachnoid cysts presented together with a rupture or hemorrhage, and larger cyst size (> 5 cm) and a recent history of head trauma were significantly associated with arachnoid cyst rupture or hemorrhage. 4 However, it remains controversial whether surgical interventions can prevent arachnoid cyst rupture/hemorrhage.
Finally, the indication of surgical treatment for intracranial arachnoid cysts remains unresolved. Further studies are needed to clarify whether surgical interventions can preserve brain development in pediatric patients with asymptomatic arachnoid cysts.
conclusions
This study demonstrated that children with middle cranial fossa arachnoid cysts were at increased risk of shunt placement following cyst fenestration, particularly if they were young and displayed head enlargement and cyst expansion before fenestration. It is important to consider whether cyst fenestration will be effective in patients with these risk factors.
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